The 22q11.2 deletion syndrome (22q11.2 DS) places affected individuals at an increased risk for neurodevelopmental/cognitive, behavioral and social-emotional difficulties. Poor cognitive functioning and intellectual disabilities, attention and executive functioning deficits, learning disorders, emotional dysregulation and impairments in social processing are common among individuals with 22q11.2 DS. Identifying risk and protective/resilience factors that can be detected in early life and can predict neurodevelopmental outcomes for people with 22q11.2 DS is of significant clinical relevance and might allow for early detection and intervention. Given the focus of this review, we will discuss the possible contributing factors that influence the neurodevelopmental outcome in 22q1.2 DS, the cognitive phenotype in 22q11.2 DS, the different developmental trajectories across life span, and the implications for clinical practice and management. 
| I N TR ODU C TI ON
Chromosome 22q11.2 deletion syndrome (22q11.2 DS), a neurogenetic condition, is the most common microdeletion syndrome estimated to affect about 1 in 2,000 live births and involving haploinsufficiency of 50 genes resulting in a multi-system disorder. Phenotypic expression is highly variable and ranges from severe life-threatening conditions to only a few associated features.
Most common medical problems include congenital heart disease (CHD) (in particular conotruncal anomalies), palatal abnormalities (most frequently velopharyngeal incompetence), immunodeficiency, hypocalcemia due to hypoparathyroidism, severe feeding/gastrointestinal differences, and subtle dysmorphic facial features (McDonald-McGinn & Sullivan, 2011; Philip & Bassett, 2011) . This wide phenotypic variability and the considerable morbidity associated with 22q11.2 DS poses significant challenges for both individual and population-based healthcare management. In light of these challenges, the International 22q11.2 DS Consortium has developed practical guidelines for managing patients with 22q11.2 DS that emphasizes the multi-system nature of the condition and includes recommendations for assessment and management Fung et al., 2015) .
Not only medical issues but also developmental/educational and behavioral/psychiatric aspects of 22q11.2 DS are major concerns for most families with a child/adolescent/adult with 22q11.2 DS . The syndrome places individuals at an increased risk for neurodevelopmental/cognitive, behavioral, and social-emotional difficulties. Deficits common in 22q11.2 DS include poor cognitive functioning and intellectual disabilities, attention and executive functioning deficits, learning disorders, emotional dysregulation and impairments in social processing. Early detection of emerging problems will allow for early intervention. The ability to identify risk and protective/resilience factors predictive of neurodevelopmental outcomes in 22q11.2 DS is therefore of obvious clinical relevance (Swillen, 2016) .
| F AC TORS CON TRI B U TI NG TO T HE NE U R ODE V EL OP ME N TA L OU T COM E IN 2Q11 . DS
Neurodevelopmental outcome in 22q11.2 DS is the result of the dynamic interaction of multiple factors: person-specific risk and protective factors, family and environmental risk and protective factors, and time/development itself (see Figure 1 ). These factors act as independ-phenotype, related to a combination of socio-economic factors and heritable components contributed by the unaffected parent) (De Smedt, 2007; Swillen et al., 1997) , genetic variation within the 22q11.2 region (Gothelf et al., 2005; Raux et al., 2007) , variants in genes on the intact 22q11.2 (McDonald-McGinn et al., 2013) , prematurity, untreated neonatal hypocalcemia (Cheung, George, & Andrade, 2014) , perioperative seizures and undetected and untreated thyroid disease in children with 22q11 DS (Shugar et al., 2015) . However, much work is still to be done in identifying other possible risk factors contributing to the neurodevelopmental outcome in 22q11.2 DS such as size of the deletion, genes within the region (COMT, PRODH, TBX1, CRKL1, etc.), the remainder of the genome/ genetic background, impact of medical problems (e.g. type and severity of CHD, number of hospitalizations, medical stress, ands preverbal trauma), personality and temperament, the level of stress sensitivity and anxiety, and the presence of developmental disorders such as intellectual disability (ID), attention hyperactivity disorder, autism spectrum disorder (ASD), and psychosis. Finally, time/development itself has its impact, and contributes to the changing and mixed neurodevelopmental outcome in individuals with 22q11.2 DS (Swillen, 2016; . (Swillen, 2016) .
| Infancy and early childhood (0-4 years)
Very few studies have been published on developmental outcome in young children with 22q11.2 DS. During infancy and toddlerhood, gross/fine and neuromotor difficulties, expressive language delays and speech problems dominate (Gerdes et al., 1999; Solot et al., 2001; Swillen et al., 2005) . Roizen et al. (2007) reported retrospective data from 88 parents with a child with 22q11.2 DS about developmental milestones. Compared to sibling and community control participants, FIG URE 1 Possible factors contributing to neurodevelopmental outcome in 22q11.2 DS. Neurodevelopmental outcome in 22q11.2 DS is the result of the dynamic interaction of multiple factors: person-specific risk and protective factors, family and environmental risk and protective factors, and time/development itself. These factors act as independent, cumulative and synergistic influences expressive language and gross motor milestones were more delayed than other areas of development. Since all above-mentioned studies were cross-sectional and included small samples, there is an urgent need for prospective, longitudinal studies using large samples on early neurodevelopmental outcome in 22q11.2 DS.
| From preschool to adolescence (4-18 years)
The majority of studies have focused on childhood and adolescence, and very little is known on the intellectual functioning of adults with (Antshel, Fremont, & Kates, 2008; Campbell & Swillen, 2005; Gur et al., 2014) . In a recent cross-sectional study (Gur et al., 2014) , the cognitive functions of 137 subjects (aged 8-21) were compared with youth with a developmental delay and medical comorbidities and with typically developing controls. Greatest deficits were observed in the domains of complex cognition (verbal language-mediated reasoning, non-verbal reasoning, and spatial processing). These impairments do continue into adulthood, with challenges in the transition to adulthood including the management of medical and psychiatric comorbidities (Bassett et al., 2005) , and the provision of educational and vocational supports (Butcher et al., 2012; Fung et al., 2015) .
| D I V ER GE NT COGN I TI V E TRA J E CTOR I ES I N 2 2Q1 1. 2 D S
Longitudinal studies in 22q11.2 DS have found a negative correlation between age and IQ scores, particularly a decline in Verbal IQ, suggesting that at least some of these individuals show a gradual decline in cognitive development as they grow into adulthood (Gothelf et al., 2005; Green et al., 2009) . Recent longitudinal studies indicate that cognitive development is variable with divergent trajectories (Duijff et al., 2012; Green et al., 2009) and that the level of intellectual ability is not necessarily stable across the lifespan of the patient (Chawner et al., 2017; . Although IQ is generally considered to be a more or less stable trait in the typically developing youth, an average decline of 7 full-scale IQ points is observed in individuals with 22q11.2DS between 8 and 24 years of age . However, there seem to be different subgroups within the 22q11.2 DS population with some children's IQ decreasing over time, while others seem to make progress (Chawner et al., 2017; Duijff et al., 2012; Swillen, 2016) .
| I M P LI CA TI ON S F OR CLI N I CA L P RA CT IC E
Although there are some guidelines and recommendations relevant for all patients, treatment must be targeted to best suit the individual, incorporating age or developmental stage, and the specific constellation of associated features, severity, and need for treatment Fung et al., 2015) . Given the increased risk for impaired neurodevelopmental outcome and deficits in several neuropsychological domains (such as attention, executive functions, visual-spatial abilities, and emotion recognition) early neurodevelopmental follow-up and intervention is warranted for individuals with 22q11.2 DS. It will be key to find a balance between follow-up and intervention, and to monitor in a flexible way the changing and increasing environmental demands with age.
Because of the delays in many developmental domains "a holistic and multidisciplinary approach" is required in follow-up and in intervention programs. This means that different caregivers (parents, teachers) and therapists from different disciplines (pediatrician, speech-language pathologist, physiotherapist and/or occupational therapist and early childhood Mercer-Rosa et al., 2015) . Acknowledging this burden and supporting parents to talk about this is crucial. In our experience parents often benefit from psychological guidance, interventions aimed at the parent/child interaction and contact with other parents.
In Table 1 , a summary is given of the developmental features and treatment recommendations in 22q11.2 DS during infancy and early childhood (0-6 years).
Type of education should be chosen depending on the overall cognitive capacities (borderline intelligence vs. ID) of primary-aged children (Antshel et al., 2008; Campbell & Swillen, 2005; Moss et al., 1999) . Areas of relative weaknesses are reading and language comprehension, arithmetics, visual-spatial memory, working memory, and executive skills (planning, problem-solving, cognitive flexibility, and monitoring) (Antshel et al., 2008; Bearden et al., 2001; Campbell & Swillen, 2005; De Smedt, Swillen, Verschaffel, and Ghesquiere, 2009b; Moss et al., 1999; Simon, Bearden, Mc-Ginn, and Zackai, 2005; Stoddard, Beckett, and Simon, 2011; Wong, Riggins, Harvey, Cabaral, and Simon, 2014; Woodin et al., 2001) .
It is our clinical experience that many children with 22q11.2 DS are helped with: a highly structured learning environment, the utilization of concrete (visual) materials and experiences, a step-by-step approach with much repetition and rehearsal, an encouraging and reinforcing learning environment with clear learning goals and frequent feedback, and instructions on how to learn and how to memorize (with visual aids and schemes) and pre-teaching (for learning new material).
Given the changing cognitive phenotype with age and the possible cognitive decline in a subgroup, the cognitive abilities of children and adolescents should be followed-up and re-evaluated on a regular basis.
Additionally, in case of a changing developmental/cognitive trajectory, realistic expectations and an adapted learning environment will be necessary to provide a good balance between the individual's capacities and the environmental demands. In this way, anticipatory guidance can be implemented at home and in school thereby averting unnecessary stress. The emergence of social deficits by the end of primary school age, can represent a major source of disability in individuals with 22q11.2 DS. Awareness for and psychoeducation about these issues for parents and school teams is recommended. Interventions should focus on appropriate adaptation of social demands by use of sociocognitive remediation programs (Glaser et al., 2012 , Mariano, Tang, Kurtz, & Kates, 2015 and/or cognitive-behavioral therapy to improve social skills (Mariano et al., 2015) , although studies are needed on the long-term effects of these interventions. As part of anticipatory care, individuals with 22q11.2 DS should be screened for social processing deficits and anxiety and mood disorders throughout the lifetime.
| CON CL U S I ON
There is a wide variability in cognitive abilities and profile in children and adolescents with 22q11.2 DS ranging from borderline intelligence to mild-moderate ID. This profile is often colored by a complex associated medical phenotype which frequently results in multiple hospitalizations beginning at an early age. It is clear that appropriate neurodevelopmental and educational support from a very young age on is critical to children affected with this condition. Children with a parent who also has 22q11.2DS are at greater risk for a poorer longterm outcome, and these families need more intense support and follow-up throughout life .
In this context, many risk and protective environmental factors are still understudied in 22q11.2 DS. Future studies should focus on parent-child interaction (attachment), parental stress/resilience, parenting style and coping, the impact of therapy/remediation/anticipatory guidance, quality of life, availability of social network support and resources.
Early educational intervention is strongly recommended, and should include training of both verbal (language, articulation, and reading comprehension) and non-verbal areas (motor skills, visual-spatial skills and memory, mathematical training, attention, and social skills).
Educational and neurodevelopmental specialists are important members of the professional multidisciplinary team which provides services to a child with 22q11.2 DS. Recognizing areas of strengths and weaknesses may help to guide educational approaches and identify additional resources that can effectively support the learning and neurodevelopmental process. Additionally, a better understanding of the challenges, these families face and the underlying neuropsychological processes, will lead to the development of appropriate and targeted intervention and proactive treatment that will help children, adolescents, and adults achieve their full potential.
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